The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis

被引:131
作者
Glasner, Dustin R. [1 ]
Puerta-Guardo, Henry [1 ]
Beatty, P. Robert [1 ]
Harris, Eva [1 ]
机构
[1] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA
来源
ANNUAL REVIEW OF VIROLOGY, VOL 5 | 2018年 / 5卷
关键词
dengue; NS1; endothelial permeability; vascular leak; immune evasion; vaccines; T-CELL RESPONSES; LINKED-IMMUNOSORBENT-ASSAY; NS1; PROTEIN; HEMORRHAGIC-FEVER; ENDOTHELIAL GLYCOCALYX; MONOCLONAL-ANTIBODIES; PLASMA LEAKAGE; YELLOW-FEVER; ION-CHANNEL; CYTOKINE PRODUCTION;
D O I
10.1146/annurev-virology-101416-041848
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Dengue virus (DENV) is the most prevalent medically important mosquito-borne virus in the world. Upon DENV infection of a host cell, DENV nonstructural protein 1 (NS1) can be found intracellularly as a monomer, associated with the cell surface as a dimer, and secreted as a hexamer into the bloodstream. NS1 plays a variety of roles in the viral life cycle, particularly in RNA replication and immune evasion of the complement pathway. Over the past several years, key roles for NS1 in the pathogenesis of severe dengue disease have emerged, including direct action of the protein on the vascular endothelium and triggering release of vasoactive cytokines from immune cells, both of which result in endothelial hyperpermeability and vascular leak. Importantly, the adaptive immune response generates a robust response against NS1, and its potential contribution to dengue vaccines is also discussed.
引用
收藏
页码:227 / 253
页数:27
相关论文
共 184 条
  • [81] Covalent modifications of the Ebola virus glycoprotein
    Jeffers, SA
    Sanders, DA
    Sanchez, A
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (24) : 12463 - 12472
  • [82] Selection and identification of B-cell epitope on NS1 protein of dengue virus type 2
    Jiang, Lan
    Zhou, Jun-Mei
    Yin, Yue
    Fang, Dan-Yun
    Tang, Yun-Xia
    Jiang, Li-Fang
    [J]. VIRUS RESEARCH, 2010, 150 (1-2) : 49 - 55
  • [83] Dextran Fractional Clearance Studies in Acute Dengue Infection
    Julie Nguyen-Pouplin
    Pouplin, Thomas
    Toi Pham Van
    Trung Dinh The
    Dung Nguyen Thi
    Farrar, Jeremy
    Hien Tran Tinh
    Wills, Bridget
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (08):
  • [84] IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever
    Karem Flores-Mendoza, Lilian
    Estrada-Jimenez, Tania
    Sedeno-Monge, Virginia
    Moreno, Margarita
    del Consuelo Manjarrez, Maria
    Gonzalez-Ochoa, Guadalupe
    Millan-Perez Pena, Lourdes
    Reyes-Leyva, Julio
    [J]. MEDIATORS OF INFLAMMATION, 2017, 2017
  • [85] Antibody-dependent enhancement of severe dengue disease in humans
    Katzelnick, Leah C.
    Gresh, Lionel
    Halloran, M. Elizabeth
    Carlos Mercado, Juan
    Kuan, Guillermina
    Gordon, Aubree
    Balmaseda, Angel
    Harris, Eva
    [J]. SCIENCE, 2017, 358 (6365) : 929 - 932
  • [86] Comparison of the Effectiveness of Zanamivir and Oseltamivir against Influenza A/H1N1, A/H3N2, and B
    Kawai, Naoki
    Ikematsu, Hideyuki
    Iwaki, Norio
    Maeda, Tetsunari
    Kawashima, Takashi
    Hirotsu, Nobuo
    Kashiwagi, Seizaburo
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (07) : 996 - 997
  • [87] Dengue virus selectively induces human mast cell chemokine production
    King, CA
    Anderson, R
    Marshall, JS
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (16) : 8408 - 8419
  • [88] ANTIBODY-DEPENDENT ENHANCEMENT OF DENGUE VIRUS GROWTH IN HUMAN-MONOCYTES AS A RISK FACTOR FOR DENGUE HEMORRHAGIC-FEVER
    KLIKS, SC
    NISALAK, A
    BRANDT, WE
    WAHL, L
    BURKE, DS
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1989, 40 (04) : 444 - 451
  • [89] STUDY OF ANTI-DENGUE NS1 ANTIBODY BY WESTERN-BLOT
    KUNO, G
    VORNDAM, AV
    GUBLER, DJ
    GOMEZ, I
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1990, 32 (02) : 102 - 108
  • [90] KURANE I, 1994, ARCH VIROL, P59